Answer
In humans, R406, the active metabolite of fostamatinib, has a mean terminal half-life of approximately 15 hours (standard deviation ±4.3 hours).
Sources for this answer
- Tavlesse 100 mg film-coated tabletsGrifols UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 3Document updated
Sources checked